The big launch of Acomplia in the UAE was announced by Sanofi-Avensis
An announcement was made about Sanofi-Aventis.This refears to the launch of Acomplia (rimonabant), a new medication that treats abdominally obese persons which presents cardio metabolic risk cluster.
This medication was approved from the European Medicines Evaluation Agency (EMEA) in order to be used,but combined with diet and sport and it’s ment to the treat obesity with cardio metabolic risk cluster.People can buy Acomplia already in more that 15 European states, including very important states like Germany and the UK.
In the Middle Eas studies showed that obesity has increased from 5% to kids and 15% in adolescent males and to a further 30% in elderly persons.The newest results from the IDEA (International Day for the Evaluation of Abdominal Obesity) shows, a 64 states study, which includes the UAE has shown that 38% of the UAE population is obese. Also,more and more experts in obesity thing that total body fat - as is showed by the body mass index (BMI) - was the primary supporter of weight-related disease, now we can understand that located of body fat is a very important factor. For more understanding, to much body fat which is set around the stomach and also abdomen is thought to be a better predictor of weight related maladies such as diabetes, and cardiovascular maladies,so to buy acomplia in the internet is a positive thing.
Internal Medicine Professor at theUniversity of Cologne ,Dr. Matthias Blüher,said : ‘Both diabetes and obesity have attain huge proportions around the world. The UAE has reached the point of being now the second in the world for diabetes, and the main cause is abdominal obesity. This new medication,acomplia, if it’s being used in combination with positive lifestyle modifications it gives an important impulse in the fight against obesity which is associated with risk factors such as type 2 diabetes,so I think people must buy acomplia.’
This new obesity drug can reduce very much the blood sugar levels in persons which have type 2 diabetes and in the same time it helps this persons to reduce their body weight. Acomplia way of working is by select and block the receptors that are located in the brain and in peripheral organs important in glucose and lipid metabolism,and that includes the liver, gastrointestinal tract, adipose tissue, and muscle. The medication is decreasing the over activity of the endocannabinoid system (EC system). The EC system was a short time ago characterized as a physiological system that includes receptors such as the CB¹ receptor, and scienties think that in order to play an very important role in controlling energy balance ,in regulating body weight and glucose and lipid metabolism.So it’s ok for people to use and buy acomplia.
1 Comment »
No comments yet.
Leave a comment
If you want to leave a feedback to this post or to some other user´s comment, simply fill out the form below.